Antiepileptogenesis and disease modification: Clinical and regulatory issues-Reference-Cited by-同舟云学术

Antiepileptogenesis and disease modification: Clinical and regulatory issues

Published:2021-07-29 Issue:3 Volume:6 Page:483-492
ISSN:2470-9239
Container-title:Epilepsia Open
language:en
Short-container-title:Epilepsia Open

Author:

French Jacqueline A.¹^ORCID,Bebin Martina²^ORCID,Dichter Marc A.³,Engel Jerome⁴,Hartman Adam L.⁵^ORCID,Jóźwiak Sergiusz⁶,Klein Pavel⁷^ORCID,McNamara James⁸^ORCID,Twyman Roy⁹^ORCID,Vespa Paul¹⁰

Affiliation:

1. NYU Grossman School of Medicine and NYU Langone Health New York NY USA

2. UAB School of Medicine and UAB Epilepsy Center Birmingham AL USA

3. University of Pennsylvania Philadelphia PA USA

4. David Geffen School of Medicine at UCLA and the Brain Research Institute Los Angeles CA USA

5. Division of Clinical Research National Institute of Neurological Disorders and Stroke/NIH Bethesda MD USA

6. Department of Child Neurology Medical University of Warsaw Warsaw Poland

7. Mid‐Atlantic Epilepsy and Sleep Center Bethesda MD USA

8. Department of Neurobiology Duke University School of Medicine Durham NC USA

9. Amron Neuroscience, LLC Darby, MT USA

10. Departments of Neurology and Neurosurgery David Geffen School of Medicine UCLA Los Angeles CA USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/epi4.12526

Reference53 articles.

1. GhaiyoumiA.Epilepsy [Internet].2019. Available from:https://www.who.int/news‐room/fact‐sheets/detail/epilepsy

2. The Cost of Epilepsy in the United States: An Estimate from Population-Based Clinical and Survey Data

3. The burden of neurological disease in the United States: A summary report and call to action

4. The economic burden of epilepsy in Australia 2019‐2020. Deloitte Access Economics.2020.

5. YangG SchmielL ZhouM CintinaI SpencerD HoganP.Economic burden and future impact of parkinson’s disease ‐ final report [Internet]. Vol. July Michael J. Fox Foundation ‐ The Lewin Group Incorporated. 2019. Available from:https://www.michaeljfox.org/sites/default/files/media/document/2019Parkinson%27sEconomicBurdenStudy‐FINAL.pdf

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Posttraumatic epilepsy: Integrating clinical, inflammatory, and genetic profiles in traumatic brain injury patients;Epilepsy Research;2024-09

2. Initial clinical evidence on biperiden as antiepileptogenic after traumatic brain injury—a randomized clinical trial;Frontiers in Neurology;2024-08-07

3. An update on the novel methods for the discovery of antiseizure and antiepileptogenic medications: where are we in 2024?;Expert Opinion on Drug Discovery;2024-07-04

4. Integrative network analysis of miRNA-mRNA expression profiles during epileptogenesis in rats reveals therapeutic targets after emergence of first spontaneous seizure;Scientific Reports;2024-07-03

5. A profile of azetukalner for the treatment of epilepsy: from pharmacology to potential for therapy;Expert Review of Clinical Pharmacology;2024-04-03